Targeting FEN1 to enhance efficacy of PARP inhibition in triple-negative breast cancer
Mallory I. Frederick, Elicia Fyle, Anna Clouvel, Djihane Abdesselam, Saima Noor Hassan
This study identifies FEN1 as a target to enhance PARP inhibitor efficacy in PARPi-resistant triple-negative breast cancer cell lines and organoids.
Translational Oncology · Mar 6, 2025Peer-reviewedCancer Biology